Related Experiment Video
Updated: Jan 18, 2026
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
γδT cells and breast cancer: wicked allies
Abhiram Charan Tej Mallu1, Seth B Coffelt1
1School of Cancer Sciences, University of Glasgow, Glasgow, UK; Cancer Research UK Scotland Institute, Glasgow, UK.
Abstract:
Metastatic disease and therapy resistance pose significant challenges in the treatment of breast cancer. Recent studies by Rozalén et al. and Petroni et al. uncover a crucial role for IL-17A-producing γδT cells in liver metastasis and therapeutic resistance, offering new insights into the mechanisms underlying these processes.
Insights
Interleukin-17A-producing gamma-delta T cells (γδT cells) are key drivers of liver metastasis and treatment resistance in breast cancer. Understanding their role offers new therapeutic strategies for advanced breast cancer.
Area of Science:
- Immunology
- Oncology
- Cancer Research
Background:
- Breast cancer metastasis and therapy resistance remain significant clinical challenges.
- The tumor microenvironment and immune cell infiltration play critical roles in disease progression.
Purpose of the Study:
- To investigate the specific role of Interleukin-17A-producing gamma-delta T cells (IL-17A+ γδT cells) in breast cancer liver metastasis.
- To explore the involvement of these cells in mediating therapeutic resistance in breast cancer models.
Main Methods:
- Analysis of immune cell populations in preclinical breast cancer models.
- Investigating the functional impact of IL-17A+ γδT cells on metastatic spread and treatment response.
Main Results:
- IL-17A-producing γδT cells were identified as crucial mediators of liver metastasis in breast cancer.
- These cells were also found to contribute significantly to resistance against established cancer therapies.
Conclusions:
- Targeting IL-17A+ γδT cells may represent a novel therapeutic strategy to overcome liver metastasis and therapy resistance in breast cancer.
- Further research into the mechanisms of IL-17A+ γδT cell function is warranted for clinical application.
